Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

March 11, 2024 12:32 (London Time)

Eyenovia

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: EYEN
Sentiment: 0.765
MarketCap: 70,154,337.0
High: 1.73 Low: 1.54

Open: 1.7 Close: 1.58 Change: -0.12

What an AI found about Eyenovia Stock after reading the whole Internet.

This document will help you to evaluate Eyenovia without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Eyenovia are: Eyenovia, March, result, acquire, US, Formosa, Monday, and the …

Concept Map

...

Semantic Network

...

Stock Summary

Eyenovia obtained the first required state pharmacy license from New York. Eyenovaia obtained first required pharmacy license. The company spent $1 million in cash..

Today's Summary

Eyenovia to report fourth quarter 2023 results and provide business update on March 18th. FDA approved APP13007 in Optejet for the dry eye market, estimated to be around $3.6 billion in the United States.

Today's News

Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th 3/11/2024. Eyenova will release financial results for the fourth quarter ended December 31, 2023 on March 18, 2024. Eyenovia to report fourth quarter 2023 results and provide business update on Monday, March 18th. FDA approved APP13007 in Optejet for the dry eye market, estimated to be around $3.6 billion in the United States. Eyenovia, Inc. (NASDAQ:EYEN) will release its Q4 2023 financial results on March 18, 2024. William Blair Research Analysts Lower Earnings Estimates for Eyenova, Inc - defense world. (nasdaq:eyen) - defense. Eyenovia acquired U.S. eyenovias strategic expansion: dual product offering enhances market position. Formosa Pharmaceuticals tapped commercial stage eyecare specialist Eyensovia in the US. Eyenovia acquired U.S. rights to distribute and sell APP13007. APP13006 is a clobetasol propionate ophthalmic nanosuspension. Eyenovia acquires u.S. commercial rights to appetasol appetol ophthalmic propetasion, 0.05% for the treatment of post-surgery patients. Eyenovia will make single-digit million-dollar payments to Formosa in cash and shares of common stock. Formosa will be eligible for payments related to the attainment of sales milestones by Eyenovaia.

Stock Profile

" Eyenovia (eyen) - Cash on Hand chart (from 2016 to 2023) Cash on hand chart. Eyenovia: It Is Now Time To See Positive Results In Their Marketing Efforts (NASDAQ:EYEN) - Seeking Alpha. Eyenovaia obtained the first required state pharmacy license from New York, allowing them to obtain the first commercial sale of their drug candidate MydCombi. Eyenovia spent $1 million in cash and offered 487,805 shares of company stock to a Taiwan-based company. Instead of leveraging and monetizing the Optejet technology, the deal was for an ophthalmic nanosuspension drug."

Keywords

How much time have you spent trying to decide whether investing in Eyenovia? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Eyenovia are: Eyenovia, March, result, acquire, US, Formosa, Monday, and the most common words in the summary are: eyenovia, fda, ophthalmic, formosa, news, surgery, approval, . One of the sentences in the summary was: FDA approved APP13007 in Optejet for the dry eye market, estimated to be around $3.6 billion in the United States.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #eyenovia #fda #ophthalmic #formosa #news #surgery #approval.

Read more →

Related Results

...
March 11, 2024 12:32 (London Time)

Eyenovia

Eyenovia to report fourth quarter 2023 results and provide business update on March 18th. FDA approved APP13007 in Optejet for the dry eye market, e…
Sector: Pharmaceuticals
Ticker: EYEN
Sentiment: 0.765
MarketCap: 70,154,337.0
High: 1.73 Low: 1.54

Open: 1.7 Close: 1.58 Change: -0.12

Read more →
...
September 02, 2023 8:33 (London Time)

Eyenovia

Eyenovia (eyen) - Cash on Hand chart (from 2016 to 2023) Cash on hand chart. Eyenovia: It Is Now Time To See Positive Results In Their Marketing Eff…
Sector: Pharmaceuticals
Ticker: EYEN
Sentiment: 0.9042
MarketCap: 74,513,025.0
High: 1.96 Low: 1.89

Open: 1.9 Close: 1.95 Change: 0.05

Read more →
...
September 03, 2023 22:59 (London Time)

Eyenovia

Short interest in Eyenovia, Inc. (NASDAQ:EYEN) Decreases By 6.5% - defense world. short interest in eyenova, inc. (nasdaq:eyen) decreases by 6. Eyen…
Sector: Pharmaceuticals
Ticker: EYEN
Sentiment: 0.9169
MarketCap: 74,513,025.0
High: 1.96 Low: 1.89

Open: 1.9 Close: 1.95 Change: 0.05

Read more →